We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transcriptome Selection Reveals Tumor Genes

By Biotechdaily staff writers
Posted on 06 Aug 2003
Researchers have identified 57 genes linked to the growth of human tumor cells. More...
These genes were pinpointed as a result of transcriptome-scale selection, which was used to isolate genetic suppressor elements (GSEs) inhibiting breast carcinoma cell growth.

The information buried in the genome of an organism is extracted by the process of transcription in which the DNA sequence of a gene is transcribed into the sequence of a messenger RNA (mRNA). The primary steps of this process are mRNA initiation, elongation, and termination. These are coupled to a huge network of post-transcriptional events that mature the mRNA into a form that can be exported from the nucleus to the cytoplasm, where it will be translated into the protein product. The whole process of transcription from initiation to export from the nucleus is highly regulated to ensure the gene products are present only at a specific time or place, for example, at a particular stage of development or in a specific tissue. The corresponding body of transcripts present at any given moment is called the transcriptome.

The strategy employed by investigators at the University of Illinois at Chicago (UIC, USA), described in the July 22, 2003, issue of Cancer Cell, required cutting human DNA into tiny, random fragments; inserting the fragments into a mammalian cell using a vector; and inducing the fragments to express their genetic information. Some of the fragments proved to be biologically active by interfering with the function of the genes from which they were derived.

"Our strategy was validated by the fact that more than half of the genes we identified were already known to play key roles in the growth of cells or the development of cancers,” explained senior author Dr. Igor Roninson, professor of molecular genetics at the University of Illinois. "Many of the other genes, however, were not previously known to be involved in cell division and proliferation. In fact, the functions of some of these genes were entirely unknown. The genes we have identified clearly have the potential to serve as targets for novel therapeutics in the fight against cancer.”



Related Links:
University of Illinois

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.